Teragen Etex Signs Industry-Academic Agreement with Dongguk University for New Drug Development and Talent Nurturing
Ryu Byung-hwan, CEO of Theragen Etex (right), and Kim Sang-geon, Dean of the College of Pharmacy at Dongguk University, signed a memorandum of understanding for industry-academic cooperation at Dongguk University on the 16th and are taking a commemorative photo. (Photo by Theragen Etex)
View original image[Asia Economy Reporter Kim Ji-hee] Theragen Etex announced on the 21st that it has signed an industry-academia cooperation agreement (MOU) with Dongguk University College of Pharmacy for joint research and fostering talent in the pharmaceutical and bio sectors.
The signing ceremony held on the 16th at Dongguk University was attended by Ryu Byung-hwan, CEO of Theragen Etex, Kim Sang-geon, Dean of Dongguk University College of Pharmacy, and other officials. Through this agreement, both institutions will conduct ▲ joint research and clinical trials for new drug development ▲ training of specialized talent in pharmaceutical bio ▲ joint use of research facilities and exchange of personnel and information.
In particular, the two institutions plan to discover new drug candidates through joint industry-academia research and carry out activities for the commercialization of related technologies such as licensing out.
Ryu Byung-hwan, CEO of Theragen Etex, said, “By combining the expertise of both institutions, we will enhance our new drug development and pharmaceutical production capabilities and ultimately achieve results in global new drug development through mutual competitiveness.”
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
Kim Sang-geon, Dean of Dongguk University College of Pharmacy, emphasized, “We will do our best to achieve practical outcomes such as new drug development by integrating the academic fields pursued by the university, including data science, biostatistics in medicine, medicinal chemistry, and translational medicine at Dongguk University Biomed Campus, with corporate capabilities.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
